Texas Oncology is categorized under Family Practice Doctors in Bedford, TX and active since 2001.
Texas Oncology was established in 2001, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Adam Davis, Administrator at the company’s single location by writing to 1615 Hospital Parkway # 300, Bedford, Texas TX 76022 or by phoning (817) 359-9000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Texas Oncology |
| Contact Person: | Adam Davis, Administrator |
| Address: | 1615 Hospital Parkway # 300, Bedford, Texas 76022 |
| Phone Number: | (817) 359-9000 |
| Website Address: | texasoncology.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Texas Oncology was started in 2001 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Adam Davis, Administrator for inquiries that concern Texas Oncology by calling the company number (817) 359-9000, as your correspondence is most welcome. Additionally, the physical location of the single location of Texas Oncology can be found at the coordinates 32.83552,-97.12542 as well as the street address 1615 Hospital Parkway # 300 in Bedford, Texas 76022.
For its online presence, you may visit Texas Oncology’s website at texasoncology.com and engage with its social media outlets through on Twitter and on Facebook.